|
OMIM |
Link |
Information gain |
01 |
|
atypical mycobacteriosis, familial, x-linked 2
|
[NCBI]
|
0.00137383
|
|
|
melkersson-rosenthal syndrome
|
[NCBI]
|
0.00098052
|
|
|
CVID
|
[NCBI]
|
0.000601153
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
0.000505953
|
|
|
CGD
|
[NCBI]
|
0.000489051
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type i
|
[NCBI]
|
0.000260595
|
|
|
arteritis, familial granulomatous, with juvenile polyarthritis
|
[NCBI]
|
0.000196473
|
|
|
TNF
|
[NCBI]
|
0.000163401
|
|
|
granulomas, congenital cerebral
|
[NCBI]
|
0.000113606
|
|
|
granulomatous disease due to combined cellular and humoral immune defects
|
[NCBI]
|
0.000113606
|
|
|
mycobacterium tuberculosis, susceptibility to
|
[NCBI]
|
0.000108703
|
|
|
SPP1
|
[NCBI]
|
9.90461e-05
|
|
|
CD44
|
[NCBI]
|
8.76281e-05
|
|
|
fountain syndrome
|
[NCBI]
|
8.26799e-05
|
|
|
sarcoidosis, early-onset
|
[NCBI]
|
7.71861e-05
|
|
|
IL12B
|
[NCBI]
|
7.39189e-05
|
|
|
CCR8
|
[NCBI]
|
7.14683e-05
|
|
|
NOD2
|
[NCBI]
|
6.43738e-05
|
|
|
granulomatous disease, chronic, autosomal recessive, cytochrome b-negative
|
[NCBI]
|
6.28292e-05
|
|
|
TINU
|
[NCBI]
|
5.94297e-05
|
|
|
TNFSF6
|
[NCBI]
|
5.65689e-05
|
|
|
leprosy, susceptibility to
|
[NCBI]
|
5.5397e-05
|
|
|
VIP
|
[NCBI]
|
5.47147e-05
|
|
|
ACE
|
[NCBI]
|
5.21739e-05
|
|
|
CF
|
[NCBI]
|
5.16126e-05
|
|
|
EPS
|
[NCBI]
|
4.79676e-05
|
|
|
hyperimmunoglobulin e recurrent infection syndrome, autosomal dominant
|
[NCBI]
|
4.46505e-05
|
|
|
CCL19
|
[NCBI]
|
4.46323e-05
|
|
|
atypical mycobacteriosis, familial
|
[NCBI]
|
4.40646e-05
|
|
|
IL27RA
|
[NCBI]
|
4.29752e-05
|
|
|
HFTC
|
[NCBI]
|
4.24297e-05
|
|
|
IL12RB1
|
[NCBI]
|
4.15577e-05
|
|
|
PTGS1
|
[NCBI]
|
3.82317e-05
|
|
|
EBI3
|
[NCBI]
|
3.82317e-05
|
|
|
LIP
|
[NCBI]
|
3.79783e-05
|
|
|
CYBA
|
[NCBI]
|
3.73343e-05
|
|
|
CYP27B1
|
[NCBI]
|
3.57544e-05
|
|
|
amyloidosis vi
|
[NCBI]
|
3.54882e-05
|
|
|
NOS2A
|
[NCBI]
|
3.26586e-05
|
|
|
CYBB
|
[NCBI]
|
2.84369e-05
|
|
|
IBD1
|
[NCBI]
|
2.81934e-05
|
|
|
aspartylglucosaminuria
|
[NCBI]
|
2.77775e-05
|
|
|
MMP3
|
[NCBI]
|
2.77775e-05
|
|
|
VEGF
|
[NCBI]
|
2.6818e-05
|
|
|
SLC11A1
|
[NCBI]
|
2.52742e-05
|
|
|
APCS
|
[NCBI]
|
2.50331e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
2.29141e-05
|
|
|
TLR4
|
[NCBI]
|
2.28041e-05
|
|
|
TGFB1
|
[NCBI]
|
2.23628e-05
|
|
|
ACP5
|
[NCBI]
|
2.13696e-05
|
|
|
IDE
|
[NCBI]
|
2.1351e-05
|
|
|
krabbe disease
|
[NCBI]
|
2.12324e-05
|
|
|
MPO
|
[NCBI]
|
2.10784e-05
|
|
|
CCL17
|
[NCBI]
|
2.07341e-05
|
|
|
SERPINA6
|
[NCBI]
|
1.62656e-05
|
|
|
LAM
|
[NCBI]
|
1.53534e-05
|
|
|
IL6
|
[NCBI]
|
1.44972e-05
|
|
|
AGER
|
[NCBI]
|
1.40741e-05
|
|
|
RA
|
[NCBI]
|
1.25108e-05
|
|
|
GJA1
|
[NCBI]
|
1.18694e-05
|
|
|
AT
|
[NCBI]
|
8.21798e-06
|
|
|
PCNA
|
[NCBI]
|
7.88627e-06
|
|
|
GNRH1
|
[NCBI]
|
6.13331e-06
|
|
|
CTGF
|
[NCBI]
|
5.83642e-06
|
|
|
ACPP
|
[NCBI]
|
5.45825e-06
|
|
|
ALB
|
[NCBI]
|
5.43909e-06
|
|
|
SOD2
|
[NCBI]
|
5.38203e-06
|
|
|
TF
|
[NCBI]
|
5.36315e-06
|
|
|
temporal arteritis
|
[NCBI]
|
4.62841e-06
|
|
|
PTK2
|
[NCBI]
|
3.95321e-06
|
|
|
PTHLH
|
[NCBI]
|
3.4318e-06
|
|
|
SLE
|
[NCBI]
|
3.02989e-06
|
|
|
EGF
|
[NCBI]
|
2.80018e-06
|
|
|
KLK3
|
[NCBI]
|
2.29018e-06
|
|
|
CEACAM5
|
[NCBI]
|
2.19171e-06
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.18845e-06
|
|
|
AFP
|
[NCBI]
|
1.99928e-06
|
|
|
MUC1
|
[NCBI]
|
1.34623e-06
|
|
|
VDR
|
[NCBI]
|
1.13349e-06
|
|
|
MG
|
[NCBI]
|
1.10677e-06
|
|
|
RNASE3
|
[NCBI]
|
8.15826e-07
|
|
|
AVP
|
[NCBI]
|
4.40001e-07
|
|
|
G6PD
|
[NCBI]
|
3.51788e-07
|
|
|
NGFB
|
[NCBI]
|
1.84767e-07
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
8.60451e-08
|
|
|
CRH
|
[NCBI]
|
4.35087e-08
|
|